No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
65 |
4. Check minimum number of eventsNone |
65 |
5. Include endpointsNone |
65 |
6. Filter based on genotype QC (FinnGen only) |
59 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Ependymoma
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of eye, brain and central nervous system
- Malignant neoplasm of eye, brain and central nervous system, including Hilmo
- Solid cancers
- Malignant neoplasm
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 59 | 34 | 25 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 48.64 | 47.40 | 50.32 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 62
- Matched controls
- 620
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
9391/3-C72.0
ICD-O-3
Ependymoma, NOS, of spinal cord
+∞
36.0
31
*
H02AB02
ATC
dexamethasone; systemic
217.8
27.0
26
*
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
+∞
21.0
19
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
+∞
19.8
18
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
+∞
17.5
16
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
229.2
17.4
17
*
130
Kela drug reimbursment
Malignant tumour
+∞
16.4
15
*
C72.01
ICD-10 Finland
Malignant tumor of the spinal cord grade II glioma
+∞
15.2
14
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
15.7
15.2
26
27
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
+∞
14.1
13
*
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
+∞
12.9
12
*
C71.74
ICD-10 Finland
Malignant tumor of the brainstem ependyoma
+∞
11.8
11
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
73.0
11.1
12
*
WF002
NOMESCO Finland
Radical radiotherapy
131.3
10.8
11
*
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
+∞
10.7
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
10.7
10
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
6.3
10.4
23
53
C71.51
ICD-10 Finland
Malignant tumor of cerebral ventricle ependymoma
+∞
9.6
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.6
9
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
9.6
9
*
D33.43
ICD-10 Finland
Spinal cord
+∞
9.6
9
*
9391/3-C71.7
ICD-O-3
Ependymoma, NOS, of brain stem
+∞
9.6
9
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
58.6
9.0
10
*
ZXE20
NOMESCO Finland
More than three and less than five hours
6.1
8.5
18
39
A04AA01
ATC
ondansetron; systemic, rectal
39.0
8.4
10
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
39.0
8.4
10
*
XX3DW
NOMESCO Finland
Time consuming IT work
16.0
8.3
13
10
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
51.8
7.9
9
*
AA1AD
NOMESCO Finland
CT of head and brain
4.6
7.8
27
89
A03FA01
ATC
metoclopramide; systemic, rectal
5.5
7.6
18
43
A04AA02
ATC
granisetron; systemic, transdermal
90.5
7.6
8
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
7.4
7
*
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
7.4
7
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
+∞
7.4
7
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
23.4
7.4
10
5
M03BX01
ATC
baclofen; systemic
34.5
7.4
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
7.3
28
99
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
19.5
7.0
10
6
N03AX16
ATC
[U] pregabalin
4.4
7.0
24
78
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
6.3
6
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
+∞
6.3
6
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
6.3
6
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.1
6.1
22
73
XKD06
NOMESCO Finland
Physiologic investigation of micturition
17.2
6.1
9
6
R4110
NOMESCO Finland
Physiotherapy
3.8
6.1
27
104
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
44
213
4.67
7.51
3.0
2.7
—
—
estimate
—
0
0
14
24
7.20
5.96
7.0
7.7
24.07
24.95
mmol/l
0.62
14
24
16
46
4.34
5.31
9.4
13.6
24.25
24.85
mmol/l
0.38
16
46
13
27
5.80
4.83
5.6
9.2
0.74
0.77
%
0.10
13
27
27
119
3.25
4.76
3.2
2.2
—
—
—
0
0
13
29
5.38
4.57
5.6
8.8
1.09
1.78
%
0.89
13
29
26
407
0.38
3.43
4.0
3.4
—
—
—
0
0
15
60
2.98
2.97
5.3
5.8
106.60
104.22
mmol/l
1.10
15
60
5
6
8.92
2.80
1.8
2.8
—
—
—
0
0
5
6
8.92
2.80
1.8
2.3
6.00
12.83
%
—
5
6
37
238
2.38
2.75
10.9
4.8
8.16
11.46
umol/l
2.64
37
222
5
8
6.67
2.41
1.6
1.1
—
—
—
0
0
5
8
6.67
2.41
1.6
1.1
—
—
—
0
0
14
62
2.63
2.28
1.9
1.5
—
—
—
0
0
5
10
5.33
2.11
1.4
1.7
—
—
—
0
0
5
10
5.33
2.11
1.0
1.6
—
—
—
0
0
6
15
4.31
2.09
4.8
5.5
18.83
22.99
nmol/l
—
6
15
28
175
2.09
2.08
3.1
3.4
—
—
—
0
0
9
33
3.01
2.03
1.4
1.4
—
—
—
0
0
26
160
2.08
1.99
4.0
2.6
2.38
2.37
mmol/l
0.13
26
143
7
22
3.45
1.94
10.0
3.5
107.00
102.73
%
—
7
22
6
17
3.79
1.88
11.7
4.6
2.95
3.16
g/l
—
6
17
42
501
0.50
1.63
5.7
5.4
2.77
2.76
mmol/l
0.05
42
472
7
144
0.42
1.45
2.0
1.7
—
—
—
0
0
21
134
1.86
1.38
5.5
4.1
0.00
0.00
estimate
-0.00
11
45
9
44
2.22
1.33
2.1
1.4
—
—
—
0
0
14
79
2.00
1.30
4.7
1.6
2.47
2.44
mmol/l
0.48
14
62
8
39
2.20
1.20
9.6
15.8
1.46
1.13
mmol/l
—
8
32
5
21
2.50
1.11
1.8
1.2
—
—
—
0
0
9
49
1.98
1.04
9.9
6.9
24.78
23.62
mmol/l
—
9
49
8
42
2.04
0.93
2.0
3.4
—
—
—
0
0
13
81
1.77
0.90
3.0
3.3
0.80
3.97
e6/l
—
5
35
8
45
1.89
0.88
2.3
1.4
—
—
—
0
0
5
98
0.47
0.87
1.2
1.5
—
—
—
0
0
8
47
1.80
0.84
3.6
6.1
—
—
—
0
0
0
24
0.00
0.81
0.0
1.2
—
—
—
0
0
15
208
0.63
0.76
2.4
2.0
1.41
1.26
mmol/l
0.24
15
178
13
86
1.65
0.73
3.0
3.2
0.40
1.07
e6/l
—
5
40
0
20
0.00
0.61
0.0
1.7
—
55.56
—
0
20
0
23
0.00
0.59
0.0
1.2
—
251.67
—
0
9
28
234
1.36
0.50
2.2
3.2
81.14
78.12
nmol/l
0.17
28
211
0
15
0.00
0.42
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
6
85
0.67
0.36
1.8
2.0
—
—
—
0
0
10
74
1.42
0.35
1.5
3.3
20.90
24.47
%
—
10
68
7
52
1.39
0.32
2.0
2.3
29.29
42.42
u/l
—
7
43
25
283
0.80
0.30
6.2
3.9
0.00
0.00
estimate
-0.00
11
47
20
173
1.23
0.25
3.0
3.5
14.82
47.22
ng/l
0.93
11
108
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
47.32
—
0
10
0
14
0.00
0.20
0.0
1.4
—
0.78
—
0
5
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
22
200
1.16
0.15
2.3
2.0
86.77
101.17
pmol/l
0.90
13
92
26
278
0.89
0.12
6.0
3.9
0.00
0.00
estimate
-0.00
11
48
46
476
0.87
0.12
5.6
6.2
37.25
38.63
mmol/mol
0.55
46
452
12
106
1.16
0.10
3.5
4.0
0.94
2.47
ug/l
2.38
12
94
26
276
0.90
0.10
5.6
3.9
0.00
0.00
estimate
-0.00
12
48
19
204
0.90
0.08
6.4
3.7
0.00
0.03
estimate
—
9
40
41
396
1.10
0.08
3.4
4.5
10.93
10.30
mm/h
0.11
41
359
6
74
0.79
0.08
1.8
2.0
—
—
—
0
0
9
86
1.05
0.07
1.9
2.0
428.78
445.91
pmol/l
—
9
74
43
429
1.01
0.00
5.0
4.5
14.33
14.67
pmol/l
0.37
43
396
18
176
1.03
0.00
1.1
1.6
0.50
0.74
u/ml
—
6
41
15
152
0.98
0.00
7.4
3.6
0.00
0.00
estimate
—
9
40
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
6.60
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
479.00
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
1.37
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
206.80
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
311.11
—
0
9
0
9
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
52.67
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
0.80
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_EPENDYMOMA – Ependymoma
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).